REDHILL BIOPHARMA LTD. (RDHL) Capital expenditures 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9,000FY2024 · since FY2015: $14,000 → $9,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $9,000 | -18.2% |
| FY2023 | $11,000 | -94.4% |
| FY2022 | $198,000 | +72.2% |
| FY2021 | $115,000 | -71.7% |
| FY2020 | $406,000 | +141.7% |
| FY2019 | $168,000 | +630.4% |
| FY2018 | $23,000 | -84.2% |
| FY2017 | $146,000 | +71.8% |
| FY2016 | $85,000 | +507.1% |
| FY2015 | $14,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice